Showing results (111-120 of 283) with videos related to
Sort By:
Pageof 29
Journal of Cardiovascular Pharmacology|July 1, 1988
Cumulative hemodynamic response to short-term treatment with flosequinan (BTS 49465), a new direct-acting vasodilator drug, in severe chronic congestive heart failureP D Kessler, M Packer, N Medina, et al.The New England Journal of Medicine|October 2, 1986
Comparison of captopril and enalapril in patients with severe chronic heart failureM Packer, W H Lee, M Yushak, et al.Cell Reports|May 4, 2024
Highly local activation of inhibition at the seizure wavefront in vivoPrajay T Shah, Taufik A Valiante, Adam M PackerJournal of the American College of Cardiology|September 1, 1985
Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failureM Packer, W H Lee, N Medina, et al.The American Journal of Cardiology|August 1, 1979
Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosinM Packer, J Meller, R Gorlin, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1993
Blue-on-yellow perimetry can predict the development of glaucomatous visual field lossC A Johnson, A J Adams, E J Casson, et al.Ophthalmology|October 3, 2001
Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS)J D Brandt, J A Beiser, M A Kass, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1993
Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetryC A Johnson, A J Adams, E J Casson, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|January 1, 1995
Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline resultsC A Johnson, J D Brandt, A M Khong, et al.The New England Journal of Medicine|January 14, 1982
Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failureM Packer, J Meller, N Medina, et al.Pageof 29